By Dennis Crouch

Edwards Lifesciences v. Medtronic (D. Delaware, 2014)

A Delaware jury has awarded Edwards Lifesciences almost $400 million in lost profit damages for patent infringement and has also determined that the infringement was willful – opening the door to an award of both treble damages and attorney fees.

The patents adjudged to be infringed and not-invalid are both related to prosthetic aortic valve stents. U.S. Patent Nos. 8,002,825 and 7,892,281. Edwards obtained the patent rights as part of a $125 million purchase of Percutaneous Valve Technologies. Judge Sleet has not yet determined whether to issue an injunction as well.

About Dennis Crouch

Law Professor at the University of Missouri School of Law. Co-director of the Center for Intellectual Property and Entrepreneurship.

One thought on “

  1. Dennis, slight correction: the ‘825 patent is owned by Edwards, but the ‘281 patent is owned by MDT. The article makes it sound as though Edwards owns both.

Comments are closed.